Vilacto Bio (Vilacto Bio) ROCE % : 0.00% (As of Jun. 2019)

View and export this data going back to 2013. Start your Free Trial

What is Vilacto Bio ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Vilacto Bio's annualized ROCE % for the quarter that ended in Jun. 2019 was 0.00%.

Vilacto Bio ROCE % Historical Data

The historical data trend for Vilacto Bio's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vilacto Bio ROCE % Chart

Vilacto Bio Annual Data

Trend

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

ROCE %

Get a 7-Day Free Trial

-880.00

Vilacto Bio Quarterly Data
	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19
ROCE %	Get a 7-Day Free Trial															-	-	-	-	-

Vilacto Bio ROCE % Calculation

Vilacto Bio's annualized ROCE % for the fiscal year that ended in Mar. 2019 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2019 )		(A: Mar. 2018 )		(A: Mar. 2019 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2019 )		(A: Mar. 2018 )		(A: Mar. 2019 )
	=	-5.721	/	( ( (0.31 - 1.246)	+	(0.538 - 3.96) )	/ 2 )
	=	-5.721	/	( (-0.936	+	-3.422)	/ 2 )
	=	-5.721	/	-2.179
	=	262.55 %

Vilacto Bio's ROCE % of for the quarter that ended in Jun. 2019 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2019 )		(Q: Mar. 2019 )		(Q: Jun. 2019 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2019 )		(Q: Mar. 2019 )		(Q: Jun. 2019 )
	=	-1.348	/	( ( (0.538 - 3.96)	+	(0.402 - 2.914) )	/ 2 )
	=	-1.348	/	( ( -3.422	+	-2.512 )	/ 2 )
	=	-1.348	/	-2.967
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2019) EBIT data.

Vilacto Bio (GREY:VIBI) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Vilacto Bio ROCE % Related Terms

Thank you for viewing the detailed overview of Vilacto Bio's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Vilacto Bio (Vilacto Bio) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vilacto Bio Inc (GREY:VIBI) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Fabriksvej 48, Suite 2607, The Seagram Building, Naestved, DNK, 4700

Website

https://www.vilacto.com

Vilacto Bio Inc is a biotech company. It operates a fully patented Lactoactive molecule for treating conditions such as inflammatory diseases, diabetics, psoriasis, and skin issues in different levels. The company is also intended to develop Lactoactive molecule for increasing the quality of its retail and medical skin cream product as well as developing products for medical applications. Its product portfolio includes lotions, skin care creams and gels, lip balms, foot creams and oils, and others.